日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomas

Tisagenlecleucel联合ibrutinib治疗复发和/或难治性大B细胞淋巴瘤成人患者

Chavez, Julio C; Napier, Ellen; Bondanza, Attilio; Lewandowski, Andrew; Mataraza, Jennifer; Quinn, David; Kwon, Paul; Locke, Frederick L; Engels, Boris; Awasthi, Rakesh; Georgala, Petrina; Leyk, Malgorzata; Hynds, David; Moschetta, Michele; Schuster, Stephen J

Retraction: miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma

撤稿:miR-101靶向ZFX通过调控MAPK/Erk和Smad通路抑制胆囊癌的肿瘤增殖和转移

Pretto, Francesca; Ghilardi, Carmen; Moschetta, Michele; Bassi, Andrea; Rovida, Alessandra; Scarlato, Valentina; Talamini, Laura; Fiordaliso, Fabio; Bisighini, Cinzia; Damia, Giovanna; Bani, Maria Rosa; Piccirillo, Rosanna; Giavazzi, Raffaella; Bao, Run-Fa; Shu, Yi-Jun; Hu, Yun-Ping; Wang, Xu-An; Zhang, Fei; Liang, Hai-Bin; Ye, Yuan-Yuan; Li, Huai-Feng; Xiang, Shan-Shan; Weng, Hao; Cao, Yang; Wu, Xiang-Song; Li, Mao-Lan; Wu, Wen-guang; Zhang, Yi-Jian; Jiang, Lin; Dong, Qian; Liu, Ying-Bin

First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations

首次人体研究:萘普生非尼(LXH254)联合或不联合斯帕塔利珠单抗治疗伴有MAPK信号通路改变的晚期实体瘤成年患者

Janku, Filip; Kim, Tae Min; Iyer, Gopakumar; Spreafico, Anna; Elez, Elena; de Jonge, Maja; Yamamoto, Noboru; van der Wekken, Anthonie J; Ascierto, Paolo Antonio; Maur, Michela; Marmé, Frederik; Kiladjian, Jean-Jacques; Basu, Sumit; Baffert, Fabienne; Buigues, Amparo; Chen, Chi; Cooke, Vesselina; Giorgetti, Elisa; Kim, Jaeyeon; McCarthy, Fiona; Moschetta, Michele; Dummer, Reinhard

A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development

一种新型自体CAR-T疗法YTB323,保留了T细胞干性,在临床前和早期临床开发中显示出增强的CAR-T细胞疗效。

Dickinson, Michael J; Barba, Pere; Jäger, Ulrich; Shah, Nirav N; Blaise, Didier; Briones, Javier; Shune, Leyla; Boissel, Nicolas; Bondanza, Attilio; Mariconti, Luisa; Marchal, Anne-Laure; Quinn, David S; Yang, Jennifer; Price, Andrew; Sohoni, Akash; Treanor, Louise M; Orlando, Elena J; Mataraza, Jennifer; Davis, Jaclyn; Lu, Darlene; Zhu, Xu; Engels, Boris; Moutouh-de Parseval, Laure; Brogdon, Jennifer L; Moschetta, Michele; Flinn, Ian W

Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer-A Retrospective UK Single-Centre Study

肺癌继发性脊髓转移压迫患者的预后因素——一项英国单中心回顾性研究

Vassiliou, Anna; Osunronbi, Temidayo; Enyioma, Synthia; Rago, Gerardo; Karathanasi, Afroditi; Ghose, Aruni; Sheriff, Matin; Mikropoulos, Christos; Sanchez, Elisabet; Moschetta, Michele; Chargari, Cyrus; Rassy, Elie; Boussios, Stergios

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors

一项针对晚期实体瘤患者的 I 期研究,旨在探索强效且选择性的 PI3Kβ/δ 抑制剂 AZD8186 的疗效。

Choudhury, Atish D; Higano, Celestia S; de Bono, Johann S; Cook, Natalie; Rathkopf, Dana E; Wisinski, Kari B; Martin-Liberal, Juan; Linch, Mark; Heath, Elisabeth I; Baird, Richard D; García-Carbacho, Javier; Quintela-Fandino, Miguel; Barry, Simon T; de Bruin, Elza C; Colebrook, Steve; Hawkins, George; Klinowska, Teresa; Maroj, Brijesh; Moorthy, Ganesh; Mortimer, Peter G; Moschetta, Michele; Nikolaou, Myria; Sainsbury, Liz; Shapiro, Geoffrey I; Siu, Lillian L; Hansen, Aaron R

Applications of Proteomics in Ovarian Cancer: Dawn of a New Era

蛋白质组学在卵巢癌中的应用:新时代的曙光

Ghose, Aruni; Gullapalli, Sri Vidya Niharika; Chohan, Naila; Bolina, Anita; Moschetta, Michele; Rassy, Elie; Boussios, Stergios

Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity

以骨髓瘤中KRAS突变图谱为特异性靶点,揭示其抗肿瘤活性。

Sacco, Antonio; Federico, Cinzia; Todoerti, Katia; Ziccheddu, Bachisio; Palermo, Valentina; Giacomini, Arianna; Ravelli, Cosetta; Maccarinelli, Federica; Bianchi, Giada; Belotti, Angelo; Ribolla, Rossella; Favasuli, Vanessa; Revenko, Alexey S; Macleod, A Robert; Willis, Brandon; Cai, Hongbo; Hauser, Joana; Rooney, Claire; Willis, Sophie E; Martin, Philip Lloyd; Staniszewska, Anna; Ambrose, Helen; Hanson, Lyndsey; Cattaneo, Chiara; Tucci, Alessandra; Rossi, Giuseppe; Ronca, Roberto; Neri, Antonino; Mitola, Stefania; Bolli, Niccolò; Presta, Marco; Moschetta, Michele; Ross, Sarah; Roccaro, Aldo M

Progression signature underlies clonal evolution and dissemination of multiple myeloma

进展特征是多发性骨髓瘤克隆演变和扩散的基础。

Shen, Yu Jia; Mishima, Yuji; Shi, Jiantao; Sklavenitis-Pistofidis, Romanos; Redd, Robert A; Moschetta, Michele; Manier, Salomon; Roccaro, Aldo M; Sacco, Antonio; Tai, Yu-Tzu; Mercier, Francois; Kawano, Yawara; Su, Nang Kham; Berrios, Brianna; Doench, John G; Root, David E; Michor, Franziska; Scadden, David T; Ghobrial, Irene M

Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer

选择性AKT激酶抑制剂卡帕替尼联合氟维司群治疗PTEN突变型ER阳性转移性乳腺癌

Smyth, Lillian M; Batist, Gerald; Meric-Bernstam, Funda; Kabos, Peter; Spanggaard, Iben; Lluch, Ana; Jhaveri, Komal; Varga, Andrea; Wong, Andrea; Schram, Alison M; Ambrose, Helen; Carr, T Hedley; de Bruin, Elza C; Salinas-Souza, Carolina; Foxley, Andrew; Hauser, Joana; Lindemann, Justin P O; Maudsley, Rhiannon; McEwen, Robert; Moschetta, Michele; Nikolaou, Myria; Schiavon, Gaia; Razavi, Pedram; Banerji, Udai; Baselga, José; Hyman, David M; Chandarlapaty, Sarat